Correlation Between C4 Therapeutics and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Neoleukin Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Neoleukin Therapeutics.
Diversification Opportunities for C4 Therapeutics and Neoleukin Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between CCCC and Neoleukin is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Neoleukin Therapeutics
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 2.18 times more return on investment than Neoleukin Therapeutics. However, C4 Therapeutics is 2.18 times more volatile than Neoleukin Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 348.00 in C4 Therapeutics on September 1, 2024 and sell it today you would earn a total of 107.00 from holding C4 Therapeutics or generate 30.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 8.33% |
| Values | Daily Returns |
C4 Therapeutics vs. Neoleukin Therapeutics
Performance |
| Timeline |
| C4 Therapeutics |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
C4 Therapeutics and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Neoleukin Therapeutics
The main advantage of trading using opposite C4 Therapeutics and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |